Back
Citius Oncology Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
55
CTOR
Citius Oncology
Last Price:
$0.90
Seasonality Move:
112.09%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTOR is experiencing slight buying pressure.
Citius Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.87 | Buy |
20-day SMA: | 0.81 | Buy |
50-day SMA: | 0.76 | Buy |
200-day SMA: | 2.52 | Sell |
8-day EMA: | 0.88 | Buy |
20-day EMA: | 0.83 | Buy |
50-day EMA: | 0.85 | Buy |
200-day EMA: | 2.78 | Sell |
Citius Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 57.1 | Buy |
Chaikin Money Flow: | 1338 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.67 - 0.89) | Buy |
Bollinger Bands (100): | (0.73 - 1.21) | Sell |
Citius Oncology Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Citius Oncology Stock
Is Citius Oncology Stock a Buy?
-
Citius Oncology share price is 0.89 while CTOR 8-day simple moving average is 0.87, which is a Buy signal.
-
The stock price of CTOR is 0.89 while Citius Oncology 20-day SMA is 0.81, which makes it a Buy.
-
Citius Oncology 50-day simple moving average is 0.76 while CTOR share price is 0.89, making it a Buy technically.
-
CTOR stock price is 0.89 and Citius Oncology 200-day simple moving average is 2.52, creating a Sell signal.
CTOR Technical Analysis vs Fundamental Analysis
Buy
55
Citius Oncology (CTOR)
is a Buy
Is Citius Oncology a Buy or a Sell?
-
Citius Oncology stock is rated a BuyThe current Citius Oncology [CTOR] share price is $0.89. The Score for CTOR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Citius Oncology Stock Info
Market Cap:
63.3M
Price in USD:
0.89
Share Volume:
21.6K
Citius Oncology 52-Week Range
52-Week High:
49.00
52-Week Low:
0.55
Buy
55
Citius Oncology (CTOR)
is a Buy
Citius Oncology Share Price Forecast
-
What is the Citius Oncology stock price today?The Citius Oncology stock price is 0.89 USD today.
-
Will CTOR stock go up or go down?Citius Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology is not overvalued.
Is Citius Oncology Stock a Buy?
-
Citius Oncology share price is 0.89 while CTOR 8-day exponential moving average is 0.88, which is a Buy signal.
-
The stock price of CTOR is 0.89 while Citius Oncology 20-day EMA is 0.83, which makes it a Buy.
-
Citius Oncology 50-day exponential moving average is 0.85 while CTOR share price is 0.89, making it a Buy technically.
-
CTOR stock price is 0.89 and Citius Oncology 200-day simple moving average is 2.78, creating a Sell signal.
Technical Analysis of Citius Oncology
Should I short Citius Oncology stock?
-
CTOR Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Citius Oncology is a Buy
-
Citius Oncology Relative Strength Index (RSI) is 57.1, which suggest Citius Oncology is overbought
-
The Bollinger Bands (25) for Citius Oncology is (0.67 - 0.89), which suggest Citius Oncology is a Sell
-
The Bollinger Bands (100) for Citius Oncology is (0.73 - 1.21), which suggest Citius Oncology is a Sell
* Citius Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.